Fact CheckerSign in

NCT06846736Enrolling by invitation

ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study

ALK Digital Pathology Outcome Prediction

Source: ClinicalTrials.gov · Last updated 26 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The Goal of this observational study is to develop an AI-driven pathologic image analysis-based classifier that can identify patients unlikely to significantly benefit from the currently utilized first-line ALK inhibitors (advanced-generation ALK inhibitors). Our goal is a classifier with final ROC-AUC value of 0.75.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
200 (estimated)
First submitted
20 Feb 2025
Start date
13 Aug 2023
Primary completion date
1 Dec 2027
Lead sponsor
Sheba Medical Center
Diseases
Lung cancer
NCT number
NCT06846736

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 13 Aug 2023 to the primary completion date, 1 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Absence of information on the last oncologic treatment received;

Other

  • Patient without a general or specific consent for this study

Who the study is looking for

  • Patient aged ≥ 18 years;
  • Patient with an oncologic disease;
  • ALK positive patients with advanced NSCLC that have received an advanced-generation ALK inhibitor treatment as the first ALK inhibitor (i.e. alectinib, lorlatinib, brigatinib or ceritinib)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sheba medical center
Coordinator of this site? Confirm its status
Ramat GanIsraelUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.